Regulation of Nutritional Metabolism in Transition Dairy Goats: Energy Balance, Liver Activity, and Insulin Resistance in Response to Berberine Supplementation

Animals
2021.0

Abstract

Simple Summary The transition period is largely marked by a decline in dry matter intake (DMI) that often leads to a negative energy balance (NEB) which, along with exaggerated insulin resistance (IR), increasing the mobilization of body fat reserves, leads to higher blood non-esterified fatty acid (NEFA) and/or beta-hydroxybutyric acid (BHBA) concentrations. These confounding factors adversely affect animal health and lactation performance. This study evaluated the impact of pre- and post-partum berberine (BBR) supplementation as a novel approach to the regulation of nutritional metabolism in transition dairy goats. In summary, BBR supplementation (2 and 4 g/d) elevated the DMI and energy balance (EB) in pre- and post-partum goats, as well as enhancing liver activity indices, showing the potential of the new therapeutic strategy in the prevention of metabolic dysfunction in transition dairy goats and in attaining an improved lactation performance as well as health. The objectives of this study were to evaluate the alleviating effects of the isoquinoline alkaloid berberine (BBR) on the energy balance (EB), glucose and insulin metabolism, and liver functionality in transition dairy goats, as reflected by blood metabolites and enzymes. Twenty-four primiparous Saanen goats were randomly allocated to four groups. Goats in each group received, ad libitum, the same basal diet during the pre- and post-partum periods of evaluation. Goats received daily0, 1, 2, or 4 g BBR (coded as CON, BBR1, BBR2, and BBR4, respectively). Dry matter intake (DMI) and milk yield were recorded daily. Blood samples were collected on days -21, -14, -7, 0, 7, 14, and 21 relative to kidding, and individual body condition scores (BCSs) were also recorded. Supplementation with either BBR2 or BBR4 increased (p < 0.05) pre- and post-partum DMI, increasing (p < 0.05) the intakes of net energy for lactating and metabolizable proteins. BBR2 and BBR4 increased (p < 0.05) post-partum milk production as well as fat-corrected milk (FCM), energy-corrected milk (ECM), and feed efficiency, indicating the alleviating effect of BBR on the negative energy balance (NEB) in transition goats. The daily ingestion of either 2 or 4 g BBR reduced (p < 0.05) plasma aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) and increased (p < 0.05) the dynamic change in the liver activity index (LAI) and liver functionality index (LFI), implying its hepatoprotective effect on transition goats. Overall, the results suggest that BBR supplementation of at least 2 g/d may help to ameliorate insulin resistance (IR) and fat metabolism disorders initiated by the NEB in transition dairy goats.

Knowledge Graph

Similar Paper

Regulation of Nutritional Metabolism in Transition Dairy Goats: Energy Balance, Liver Activity, and Insulin Resistance in Response to Berberine Supplementation
Animals 2021.0
Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice
Bioorganic &amp; Medicinal Chemistry 2022.0
8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models
Bioorganic &amp; Medicinal Chemistry 2010.0
Inclusion of Cocoa Bean Shell in the Diet of Dairy Goats: Effects on Milk Production Performance and Milk Fatty Acid Profile
Frontiers in Veterinary Science 2022.0
A High Dose of Dietary Berberine Improves Gut Wall Morphology, Despite an Expansion of Enterobacteriaceae and a Reduction in Beneficial Microbiota in Broiler Chickens
mSystems 2023.0
Adipose Tissue SIRT1 Regulates Insulin Sensitizing and Anti-Inflammatory Effects of Berberine
Frontiers in Pharmacology 2020.0
Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
Frontiers in Pharmacology 2022.0
A Mechanistic Review on How Berberine Use Combats Diabetes and Related Complications: Molecular, Cellular, and Metabolic Effects
Pharmaceuticals 2023.0
Berberine protects cyclophosphamide and busulfan-induced premature ovarian insufficiency in mouse model
Journal of Pharmacological Sciences 2023.0
Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells
European Journal of Pharmacology 2020.0